SV-BR-1-GM in Metastatic or Locally Recurrent Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breastcancer|Breast Neoplasm
Interventions: BIOLOGICAL: SV-BR-1-GM|DRUG: Cyclophosphamide|BIOLOGICAL: Interferon-alpha-2b
Sponsor: BriaCell Therapeutics Corporation
Collaborators: Cancer Insight, LLC